Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intragastric injection of botulinum toxin A for treatment of obesity
2005-001095-13Phase 2Completed
- Sponsor
- Medical University of Innsbruck
- Start
- May 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in class III obesity, sponsored by Medical University of Innsbruck. Started May 2005; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
class III obesity
Beyond the preview
Go deeper on 2005-001095-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001095-13.